Friday, August 22, 2014 1:32:49 PM
http://www.forbes.com/sites/scottgottlieb/2014/08/18/as-the-ebola-outbreak-expands-these-experimental-drugs-could-see-action/
So, knowing that a decade old FDA rule existed, why is it that some of taxpayers money has not been allocated to try out once more our intelligent technology? When will NanoViricides, Inc. get a few million, of taxpayers money, to show that we have an effective EbolaCide candidate to destroy the Ebola virus? Not only that, we also have a new cGMP Pilot Plant ready to produce enough quantities to protect the Ebola plague fighters and restore their credibility in that part of the world, by saving the lives of thousands. All we need is enough funding to test EbolaCide's efficacy at a BSL-4 lab first and once successful, enough funding to produce quantities to eradicate Ebola from West Africa. That is not to much to ask considering hundreds of millions, of taxpayers money, have been spent with handpicked companies other than ours. Once we are funded, lets see who wins the race to eradicate the Ebola virus.
http://www.motherjones.com/politics/2014/08/new-drugs-and-vaccines-cant-stop-ebola-outbreak
EbolaCide are trillions of nanoviricides in one dose that will target/attach to the Ebola virus structures, "locking" Ebola's viral machinery and destroy them in the trillions, in a matter of hours.
Dr. Eugene Seymour, CEO NanoViricides, Inc., describes the "modus operandi" of the Ebola virus which is key to the design of the EbolaCide candidate:
Now, the following is news on a vaccine that has been in the works for years, with government-taxpayers greased skids and all...
How experimental, as the governments claim, is experimental? Shouldn't we be testing the experimental vaccine in West Africa before it spreads any further? Can the government chew (clinical trials) and walk (administer the vaccine around regions of infection) at the same time? And how about the WHO and Nanosilver? in what stage of development is that other drug? Are taxpayers paying for that as well?
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM